Rocket Pharmaceuticals Inc header image

Rocket Pharmaceuticals Inc

RCKT

Equity

ISIN null / Valor 39764376

NASDAQ (2026-03-27)

USD 3.77-19.6%

Rocket Pharmaceuticals Inc
UMushroom community rating:

4.00 1 votes No rating yet

NegativeNeutralPositive

About company

Rocket Pharmaceuticals Inc. is a New York–based, Nasdaq‑listed clinical‑stage biotechnology company developing gene therapies for rare, inherited pediatric diseases. The firm advances both ex vivo lentiviral approaches—principally via genetically modified hematopoietic stem cells—and in vivo AAV‑based therapies, with clinical programs targeting hematologic, neuromuscular and cardiac genetic disorders. In addition to advancing multiple clinical candidates, Rocket operates internal vector manufacturing and development capabilities to support its trials and regulatory filings, positioning itself as a developer of durable, one‑time genetic interventions for severe monogenic conditions.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-52.2%1Y

-77.3%3Y

-91.9%5Y

Performance

131%1Y

88.7%3Y

84.2%5Y

Volatility

409 M

Market cap (USD)

23,207,222

Daily traded volume (Shares)

12.25 / 11.56

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

4.00

1 votes

Performance:

4.00

Innovation:

4.00

Society:

2.00

Nature:

2.00

Pascale Gonzalez

Switzerland, 16 Apr 2025

So la la

EQUITIES OF THE SAME SECTOR

Intra-Cellular Therapies Inc

Intra-Cellular Therapies Inc Valor: 23194616

Annual Return

-50%0%+50%

Risk level

110

0.00%USD 131.87

Denali Therapeutics Inc

Denali Therapeutics Inc Valor: 39149539

Annual Return

-50%0%+50%

Risk level

110

-7.98%USD 18.16

GE Healthcare Technologies Inc

GE Healthcare Technologies Inc Valor: 123735674

Annual Return

-50%0%+50%

Risk level

110

-3.23%USD 69.23

Option Care Health Inc

Option Care Health Inc Valor: 52359365

Annual Return

-50%0%+50%

Risk level

110

-1.73%USD 27.27

Boiron SA

Boiron SA Valor: 487646

Annual Return

-50%0%+50%

Risk level

110

1.56%EUR 26.00

Laboratorios Farmaceuticos Rovi, SA

Laboratorios Farmaceuticos Rovi, SA Valor: 3591807

Annual Return

-50%0%+50%

Risk level

110

-0.57%EUR 78.90

Roche Holding Ltd

Roche Holding Ltd Valor: 1203204

Annual Return

-50%0%+50%

Risk level

110

-0.10%CHF 312.50

Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals Inc Valor: 33395434

Annual Return

-50%0%+50%

Risk level

110

-1.56%USD 510.68

Evotec SE

Evotec SE Valor: 505433

Annual Return

-50%0%+50%

Risk level

110

-1.60%EUR 4.30

Limes Schlosskliniken AG

Limes Schlosskliniken AG Valor: 38625581

Annual Return

-50%0%+50%

Risk level

110

-0.83%EUR 476.00

SIX

FactSet

Clearbit

Logos provided by Clearbit